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Abstract While all of medicine is under pressure to
increase transparency and accountability, joint replacement
subspecialists will face special scrutiny. Disclosures of
questionable consulting fees, a demographic shift to
younger patients, and uncertainty about the marginal ben-
eﬁts of product innovation in a time of great cost pressure
invite a serious and progressive response from the profes-
sion. Current efforts to standardize measures by the
National Quality Forum and PQRI will not address the
concerns of purchasers, payors, or policy makers. Instead,
they will ask the profession to document its commitment to
appropriateness, stewardship of resources, coordination of
care, and patient-centeredness. One mechanism for
addressing these expectations is voluntary development of
a uniform national registry for joint replacements that
includes capture of preoperative appropriateness indicators,
device monitoring information, revision rates, and struc-
tured postoperative patient followup. A national registry
should support performance feedback and quality
improvement activity, but it must also be designed to sat-
isfy payor, purchaser, policymaker, and patient needs for
information. Professional societies in orthopaedics should
lead a collaborative process to develop metrics,
infrastructure, and reporting formats that support continu-
ous improvement and public accountability.
Introduction
American employers provide healthcare beneﬁts to
158 million Americans and pay an average of over $8,000
per employee per year in healthcare costs [13, 24]. For
many years, they operated in the belief that qualiﬁed pro-
fessionals will make sound judgments, do only what is
medically indicated, and act in the best interests of patients.
Health insurance plans are expected to screen unqualiﬁed
practitioners from the network, provide a moderate level of
utilization review and oversight to avert abuses and fraud,
and establish modest incentives to encourage clinical
improvement. Employers write checks to the health plans,
and the plans write checks to the providers, with some
conﬁdence that their employees and their family members
will harvest the beneﬁts of a skilled and largely self-
regulating professional enterprise. However, due to an
enormous escalation of costs and the onslaught of data
describing the safety, quality, and service failures of U.S.
healthcare, employers today feel compelled to take on a
more direct oversight role and abandon the model they
used in the past.
Most employers are capitalists and expect market forces
of competition to drive continuous improvement and efﬁ-
ciency rather than external, let alone governmental,
regulation. Perhaps naively, employers imagine that health
plans will include high-performing physicians in their
preferred networks, will reward them with increased
compensation, and that greater use of these high-perform-
ing physicians will both lower total costs and motivate
other physicians to adopt similarly efﬁcient clinical
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availability of standardized information on the cost and
quality of care delivered by individual physicians and other
business units. Many studies show that variations in quality
and cost can ultimately be attributed to individual physi-
cian behavior rather than to organizational factors [25]. For
this reason—and particularly in specialties where critical
decisions and techniques are literally in the hands of one
person—employers have recently emphasized the impor-
tance of acquiring standardized performance information at
the individual practitioner level.
Orthopaedics has not, historically, been a priority focus
area for employers concerned about the cost and quality of
healthcare services. Most of the expensive procedures,
particularly total joint replacement, have been concentrated
among older patients covered by the Medicare program.
Since the mid-1990s, however, the frequency of knee
replacement procedures, in particular, has increased dra-
matically among patients under age 65 (Fig. 1). Recent
studies suggest orthopaedic surgeons vary widely in both
quality performance and efﬁciency of resource use. One
recent consulting analysis of quality and cost suggests an
opportunity to raise both quality and affordability by
[20% by closing the gap between average and best-per-
forming orthopaedic surgeons (Fig. 2) (personal
communication: Daniel Dunn, Senior Vice President of
Research and Development, Ingenix, 11/20/08).
Employers are now paying attention to the full range of
issues in healthcare decision making and management:
cost, appropriateness, quality, and safety. This paper
reviews purchasers’ concerns about contemporary ortho-
paedic practice and suggests that a new relationship is
needed between providers and purchasers. This new rela-
tionship will be built upon greater transparency and a
commitment to disciplined self-examination of orthopaedic
practice, health outcomes, and appropriate use of resources.
We summarize purchasers’ information expectations in
support of orthopaedic contracting, and likely uses of
performance information to affect payment and consumer
beneﬁt designs.
Purchaser Concerns Regarding Orthopaedic Practice
Cost
By 2006, over 550,000 knee replacements were being
performed in the United States at an aggregate cost of
about $21 billion, with about $8 billion of that being paid
by U.S. employers through commercial insurance plans. In
2006, employers spent an additional $4.6 billion (of the
$16 billion national total) on hip replacements for com-
mercially insured patients. The proportion of total hip
replacements being performed on patients under age 65 has
also increased, now accounting for 45% of procedures. And
all of these rates continue to increase at 10% to 15% per
year [3, 14]. Many other orthopaedic procedures are also of
interest to employers, of course, including arthroscopies
and back surgeries.
Appropriateness
Beyond the escalation in absolute costs, the apparent shift in
utilization to a younger population raises questions about
changes in indications for these procedures. Has the prev-
alence of knee disorders increased? Are employees
experiencing more joint-related pain and disability than ten
years ago? Or has the professional threshold for joint
replacement surgery been lowered? Are all of these ‘‘new’’
procedures indicated? With widespread evidence of supply-
sensitive care in other disciplines, do we need to examine
the appropriateness of orthopaedic procedures too [21, 22]?
Quality
Orthopaedists have participated in the considerable recent
activity around quality measurement, largely focused on
the National Quality Forum and Physicians Quality
Reporting Initiative sponsored by CMS. The 2008 PQRI
measures (Fig. 3) are notably deﬁcient in addressing the
concerns or expectations of employers or the value prop-
osition that these procedures offer to patients: improved
functioning and reduced pain.
Certainly, there is substantial evidence that total joint
replacements effectively relieve symptoms and improve
0
100000
200000
300000
400000
500000
600000
1997 2002 2006
%
 
o
f
 
t
o
t
a
l
 
p
r
o
c
e
d
u
r
e
s
Younger patient mix for knee replacement
65+
<age 65
Fig. 1 Frequency of knee replacement procedures, by age: 1997 to
2006. (Source: DeFrances CJ, Lucas CA, Buie VC, Golosinskiy A.
2006 national hospital discharge survey. Natl Health Stat Report.
2008;5:1–20. Available at: http://hcupnet.ahrq.gov. Accessed Nov. 1,
2008.)
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123function. But international comparisons invite questions
from the employer community now paying a larger share of
these costs. A 2006 study by the Australian Centre for
Health Research found a rapid increase in the use of ce-
mentless ﬁxation for THR in the ﬁrst half of this decade
(from 40% to 58% between 2001 and 2005) coupled with
wide regional variation (90% in Tasmania versus 36% in
Queensland in 2005, for example) [9]. The Canadian
national rate in 2007 was 70% in 2006 [1]. In Sweden,
however, only 3.4% of hip replacements use cementless
ﬁxation and national practice is to limit prosthesis selection
to a few devices. Remarkably, the AAOS statistical staff is
not able to make public any estimates of ﬁxation practice in
the United States (personal communication with Kristin
Hitchcock, Medical Librarian, 11/7/08). The Australian
analysts observe: ‘‘The reason for these differences relates
to the inﬂuence of the long established hip and knee reg-
istries in Sweden. The identiﬁcation of the best performing
prostheses and techniques is known to signiﬁcantly inﬂu-
ence prostheses selection and the practice of joint surgery
in that country. … An important observation is that the
Swedish experience has not inﬂuenced the practice of joint
replacement worldwide’’ [9, 15].
The key quality indicator for the employer is patient
outcome: are patients able to resume high levels of func-
tioning and is this functioning sustained over time? Two
simple outcome measures appeal to us: functional
improvement as measured by a patient-reported self-
assessment (eg, Oxford Hip Score, EQ-5, etc) and revision
rate. In Sweden, for example, the national registry is able to
2008 PQRI Measures Applicable to Orthopaedics (from AAOS)
Clinical Measures
4. Screening for Future Fall Risk  
20. Perioperative Care: Timing of Antibiotic Prophylaxis - 
Ordering Physician  
21. Perioperative Care: Selection of Prophylactic Antibiotic - First 
OR Second Generation Cephalosporin 
22. Perioperative Care: Discontinuation of Prophylactic 
Antibiotics (Non-Cardiac Procedures) 
23. Perioperative Care: Venous Thromboembolism (VTE) 
Prophylaxis (When Indicated in ALL Patients) 
24. Osteoporosis: Communication with the Physician Managing 
Ongoing Care Post Fracture 
39. Screening or Therapy for Osteoporosis for Women Aged 65 
Years and Older 
40. Osteoporosis: Management Following Fracture 
41. Osteoporosis: Pharmacologic Therapy 
126. Diabetic Foot and Ankle Care, Peripheral Neuropathy: 
Neurological Evaluation 
127. Diabetic Toot and Ankle Care, Ulcer Prevention: Evaluation 
of Footwear 
Administrative Measures
124. HIT – Adoption/Use of Health Information Technology 
(Electronic Health Records) 
125. HIT – Adoption/Use of e-Prescribing 
Fig. 3 The2008PQRImeasuresapplicabletoorthopaedicsareshown.
(Available at: http://www.aaos.org/research/committee/evidence/
pqri_measures.asp; accessed June 20, 2009. Reprinted with permis-
sionand AmericanAcademyofOrthopaedicSurgeons.AAOShasan
updated list and Measure 4 (Screening for Future Fall Risk) was dis-
continued in 2009, but replaced by Measures 154 & 155 Falls—Risk
Assessment (Measure 154) and Plan of Care (Measure 155). Measure
125—HIT Adoption/Use of E-Prescribing has been removed from the
PQRI list and is now a separate reporting mechanism.)
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123report very favorable outcomes showing that patients age
75 to 79 years achieve comparable EQ5D scores to the
general population at 6 years postoperation. These data are
not routinely available in the United States, which makes
the value proposition for employers difﬁcult to assess.
Similarly, the only published information on revision
rates in the United States provides the proportion of annual
procedures performed as revisions, rather than a Kaplan-
Meier estimate of cumulative revision rates. In the absence
of cumulative revision rates and rigorous, continuous
analysis, it is difﬁcult to understand the value of new
device models and processes. The absence of such data for
joint prostheses can be contrasted with the rich history of
survival modeling for heart valves which has led both to
relative product stability and well-deﬁned indications for
product selection [7, 20].
Safety
Perioperative complications are generally infrequent for
total joint replacement, but the considerable attention given
to deep-vein thrombosis prevention is not fully reﬂected in
current practice. One recent study reported that most
patients receive DVT prophylaxis, but that only 47% of
THA and 61% of TKA patients in the United States receive
prophylaxis services consistent with the recent ACCP
guidelines—in terms of type, duration, start time, and dose
[6]. Compliance may be greater with the AAOS guidelines
on pulmonary embolism prevention, but no data on practice
conformity are available [4]. Such evidence suggests broad
variations in orthopaedic safety and quality performance
across hospitals. A Pennsylvania study of 3769 knee
replacement procedures found wide variations in compli-
cation and readmission rates and concluded ‘‘the hospital in
which the procedure was performed was the most powerful
predictor of risk adjusted in-hospital complications
(n = 400). Thirty-day readmission (n = 170) rates ranged
between 0 and 8.8%’’ [23].
Strategies to Address Purchaser Concerns
As U.S. healthcare purchasers become alert to the growing
cost and signiﬁcance of orthopaedic services in the
employed population, and start to explore these dimensions
of quality and value, they see a mixed picture. They
observe a generally effective and desirable service that
lacks transparency in the four key areas of their concern.
They see steadily escalating utilization and costs, rapid
adoption of new technologies without evidence of incre-
mental value, and wide variations in practice and
outcomes. These concerns are compounded by recent press
attention to the dangers of a system lacking transparency
and strong professional self-regulation. In late 2007, the
Department of Justice entered into deferred prosecution
agreements based on evidence of inappropriate marketing
and incentive practices among the large device manufac-
turers [5]. The resulting publication of extraordinary
consulting fees further raised questions regarding the
commitment of participating surgeons to exercising inde-
pendent medical judgment.
The trend over the past decade of continued price
escalation for devices, and the primary technology focus on
cementless devices without evident incremental beneﬁt for
most patients, compounds the concern that manufacturers
are excessively inﬂuencing the choice of therapies. The
Australian review of 103 recently introduced devices found
that ‘‘new prostheses were almost universally at the top end
of the market with respect to cost; in particular almost all
were cementless components. It appears that sponsors and
manufacturers are not developing prostheses for cement
ﬁxation despite evidence from the Swedish registries and
now more recently the Australian registry that they have
better outcomes’’ [9].
Finally, the recent press attention to the recognition of
the design ﬂaws of the Durom cup and the particularly slow
response by U.S. surgeons to data available internationally
highlights purchasers’ concerns [16].
Faced with these challenges, contemporary healthcare
purchasers are seeking ways to assure that their employees
and dependents receive appropriate and effective care and
achieve the best possible outcomes. Given the wide vari-
ability we observe in the clinical and cost performance of
hospitals and physicians, one mechanism of quality
improvement is to identify high-performing providers,
processes, and products and encourage patients to seek
them out. The presumption is that this ‘‘market signal’’ will
encourage all providers to try to achieve comparable or
superior clinical and cost outcomes, which will in turn
encourage greater use of quality improvement support
systems, best practice protocols, and care coordination
strategies.
Examination of low-cost, high-quality physician exem-
plars suggest that they do not differ in their mindset from
leaders in any other sector of the economy. One founda-
tion-funded study of primary care practices that excelled on
low total cost of care for chronic illness patients found two
overarching foci of their clinical work: (1) frequent ‘‘tin-
kering’’ with their care methods in order to continuously
reduce wasteful resource use and costly treatment com-
plications; and (2) selecting referral resources (specialists,
hospitals, drug, and equipment suppliers) who similarly
deliver superior clinical outcomes for a lower total cost
[17]. These exemplars illustrate the central point that
whether motivated internally or by public release of
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123physician performance comparisons, continuous striving to
migrate towards the ‘‘northwest quadrant’’ (Fig. 2) is the
only path by which the U.S. healthcare system can remain
affordable to nonwealthy Americans if we also wish to
maintain the rate of technology-enabled clinical outcome
gains.
Today, employers, health plans, and patients, as well as
referring physicians, are all unable to identify high-per-
forming orthopaedic surgeons from any systematic data,
public or private. If such data were available, we would see
a variety of methods deployed to encourage (1) selection of
high-performing physicians; (2) greater engagement of
patients in care decisions; and (3) greater professional
adoption of practice standards and quality improvement
techniques. Such data would be used by doctors to
improve, by patients to choose, and by purchasers to
reward.
For example, clinical and cost performance data could
support several patient-facing techniques, such as reduced
co-pays for selecting better-performing surgeons; shared
decision making prior to knee replacement surgery;
workplace education on musculoskeletal issues, prevention
techniques, etc. [2]; and patient ratings networks (eg,
HealthCareScoop.com). Employers would also encourage
adoption of several provider-facing techniques—largely
administered by health plans—such as recognition of high-
performing physicians in provider directories, referral
systems, etc; bonus payment for outcomes reporting and
attainment of superior performance; incentives for involv-
ing patients in shared decision-making protocols;
incentives for participation in uniform clinical registries
with public reporting; disincentives for care without ade-
quate documentation of indications, failure to comply with
ACCP prophylaxis guidelines, etc.; and bundled payment
for episodes of care (to include rehabilitation, potential
DVT or other complications). These market-oriented
incentives for appropriate, cost-effective care all depend
upon a robust and reliable information base, which is
unavailable today. In the absence of clinically sound
information, payor and regulatory concerns could be
expressed in blunt-instrument techniques of cost control
and network design. Instead, a constructive approach to
value-based orthopaedic practice would build upon an
enhanced clinical registry approach, with several important
components, including (1) a uniform, national and uni-
versal total joint replacement registry, including standard
speciﬁcations for patient, procedure, and device charac-
teristics and indications for the procedure; (2) a uniform
battery of outcomes measures, including standard speciﬁ-
cations for preoperative functional and symptom
assessment and corresponding postoperative outcomes
(including complications, revisions, functioning, patient
experience with care, and total costs); and (3) interfaces to
related data systems, including payor claims data for
acquisition of both cost and late outcomes information.
A number of regional or enterprise joint replacement
registries are already in place, including those in the Kaiser
Permanente system and at Massachusetts General Hospital,
for example [10, 12, 15, 19]. These systems were often
built upon the experience of the established national reg-
istries in Norway, Sweden, and Australia as well as the
GLORY global registry [8].
Challenges Ahead
Certainly there are no substantial scientiﬁc or intellectual
barriers to creating a ﬂow of information that would sup-
port continuous improvement, patient safety, patient
decision making, and market-based incentives. Existing
registries have developed many of the data deﬁnition and
coding requirements, there are numerous validated instru-
ments for assessing disability and outcome, and other
systems are implementing routine patient followup
including the Swedish national registry and the National
Health Service launch of patient-reported outcomes mea-
sures in 2009 [18]. But there are marked cultural,
economic, political, and technical challenges.
Purchasers are pleased to see growing professional
interest in clinical registries but also view such programs
as insufﬁcient. They often reﬂect a well-intended but
inadequately responsive view of accountability and
improvement—one rooted in professional aspirations of
clinical excellence but tone-deaf to the realities of the con-
temporary healthcare system described above. Purchasers
arenotconvincedthatfeedbackofperformanceinformation,
by itself, leads to adjustments in clinical behavior sufﬁcient
to balance the ﬁnancial incentives favoring high utilization,
rapidadoptionofunproventechnologies,anduncoordinated
care across the continuum. Instead, we encourage develop-
ment of a database of registry, outcomes, and cost
information as a reliable resource for supporting perfor-
mance-based payment, public recognition, and professional
improvement efforts.
These purchaser expectations suggest the value of a
dialogue between orthopaedic professionals and those who
pay for and consume their services. Clearly, orthopaedic
surgeons will be reluctant to participate in a voluntary data
gathering activity which may expose unfavorable aspects
of their performance. As Henrik Malchau noted in a recent
interview, ‘‘orthopaedic surgeons are also concerned that
data from the registry will be used to monitor their per-
formance as surgeons. They are afraid of being excluded
from doing certain procedures. We need to address this
problem and assure surgeons that this will not be the case’’
[11]. Purchasers do not share this view, of course. They and
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123the patients they represent believe strongly that poor per-
forming physicians should be excluded or disincented from
performing some procedures. Patients certainly have a right
to know how skilled their surgeon is, how many cases he or
she performs, and what short- and long-term outcomes are
achieved. It would be understandable, even desirable, for
this level of transparency to reduce the ﬂow of patients to
low-performing surgeons.
The introduction and evolution of a national joint reg-
istry could be structured to address these concerns. It could
begin by asking payors to offer ﬁnancial incentives for
surgeons’ participation, with an agreement not to disclose
individual performance information for 2 years; commis-
sion a balanced panel of surgeons, referring physicians,
payors, and patients to identify a subset of indicators to be
reported to the public at Year 3; depending upon partici-
pation levels, consider mandatory contribution to the
registry; the sponsor of the Virginia state registry believes
this essential [12].
A second set of challenges involves the mechanics of
data acquisition and processing. Today, most registry data
are collected through chart abstraction or management of a
parallel set of forms by nurses and other personnel. Col-
lection of data from patients is equally burdensome and
expensive, often requiring frequent callbacks and man-
agement of voluminous paper forms. Advocates of an
enhanced national registry should undertake an information
systems analysis, optimized to take advantage of contin-
uing developments in information technology. Key
elements would include standardization of coding and
terminology for a core set of items; identiﬁcation of elec-
tronic interfaces from hospital, practice management, and
payor systems for as much data as possible; capture of
patient e-mail addresses preoperatively and maximal use of
online reminders and forms to gather followup data; use of
multidisciplinary data systems wherever appropriate, such
as the NIH PROMIS Surgical Outcomes Module and the
ACS SCIP measures; longitudinal interface to health plan
and vital statistics data systems to capture readmissions,
revisions, deaths, and full-episode costs of care.
Discussion
Employers want their employees to receive necessary and
effective medical care, and they want to encourage pro-
viders to deliver care with the most efﬁcient use of
resources. They believe there are wide variations in the
performance of orthopaedic surgeons, in terms of quality,
appropriateness, and careful stewardship of resources.
Health care purchasers and payors are prepared to support
joint replacement registries and other systems for providing
clinically rich feedback to surgeons while also bringing
new information into the hands of referring physicians and
patients so that they, too, can make better decisions about
when and where to seek care.
This paper has reviewed both the data systems and
administrative mechanisms that could support a new and
more transparent relationship between surgeons and the
larger community of purchasers, payors, and patients.
Many dimensions of this new arrangement have not been
broadly tested in this country. Some large systems—such
as Kaiser Permanente and the Veterans Health Adminis-
tration—have implemented registries with clinical
feedback, but these have generally not included transpar-
ency to the public. Other disciplines, such as cardiology,
have moved further in building links between the registry
technology and the ability to provide feedback on confor-
mity to professionally deﬁned appropriateness criteria.
Other countries, including Australia, Norway, and the
United Kingdom, have operated national joint replacement
registries and systematic patient outcomes reporting. We
have ample evidence that these approaches provide value
and lead to both care improvements and greater efﬁciency,
but they have not yet been applied to the broad community
practice of orthopaedic surgery.
Employers generally do not like centralized and regu-
latory approaches to controlling prices or limiting the
availability of services. Instead, they would like to recog-
nize and reward providers who deliver safe, high-quality,
and efﬁcient care—and who are committed to continuous
improvement across these dimensions. They believe that
such recognition will stimulate a widespread commitment
to measurable improvement and innovation. But this
‘‘market-based’’ approach to purchasing requires a shared
understanding of accountability and a shared commitment
to transparency.
The idea of accountability needs to reﬂect orthopaedic
surgeons’ participation in a large and complex ecosystem,
one which entails an enormous and growing transfer of
wealth from America’s workers to its health professionals.
Orthopaedic surgeons occupy an important space along the
care continuum, alongside and interacting with primary
care physicians, other specialists, rehabilitation services,
pharmacists, and many community resources. Perhaps
training and economics focus the orthopaedist’s attention
on the immediate requirements of the procedure, but the
employer sees that procedure in a broad context, and looks
for opportunities to reduce the need for those procedures
and, when indicated, to maximize the likelihood of a good
outcome. For employers, the key ingredients of the infor-
mation infrastructure will be evidence that procedures are
undertaken appropriately, that the least costly, effective
devices and related services (eg, imaging) were used, and
that patients ultimately achieved the intended functional
gains.
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sure of proprietary information, or violation of patient
privacy. Instead, it is based upon society’s understanding
that evidence of variation in safety, quality, and cost
exposes patients to risk and uncertainty. And it reﬂects the
recognition that physicians cannot identify opportunities
for improvement without a view of patient experience
outside of their own practice.
Our national healthcare industry needs to discover
mechanisms for achieving a 2% to 2.5% annual reduction in
total cost of care if we are to continuously offset the cost-
additive impact of valuable biomedical advances. Com-
pared to other specialties, the clinical and cost
consequences of orthopaedic surgery are more greatly
inﬂuenced by the surgeon’s skill and choice of resources,
such as orthopaedic implants. Because orthopaedicimplants
comprise such a major component of total episode cost,
more value-sensitive selection by orthopaedic surgeons
offers substantial opportunity for shared savings arrange-
ments with patients and payors. Ultimately, orthopaedists
will also need to master more nuanced methods of contin-
uous process improvement used routinely in other complex
service industries—which will in turn depend upon a rich
ﬂow of clinical and outcomes information. As evidenced by
the early successes of Medicare’s physician-focused dem-
onstrations, the most plausible scenario for a ‘‘win-win’’
translation of performance transparency into health and
ﬁnancial beneﬁt for nonwealthy Americans will involve
continuous improvement leading to ‘‘shared savings’’
between payors and providers. Orthopaedists are uniquely
positioned to ‘‘do good and do well’’ in an era of increasing
clinical performance transparency and accountability for
long-term outcomes and lower total cost of care.
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